false
OasisLMS
Catalog
SCCM Resource Library
How Do We Treat Pediatric Venous Thromboembolism?
How Do We Treat Pediatric Venous Thromboembolism?
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this conference presentation, a hematologist discusses the treatment of pediatric venous thromboembolism (VTE), especially in ICU settings. Key points include the use of various anticoagulants, some off-label, in children. Unfractionated heparin and low molecular weight heparin are highlighted for their roles in targeting specific coagulation factors, with notes on their reversibility and monitoring requirements. Bivalirudin, a direct thrombin inhibitor, is gaining popularity despite its lack of reversibility, due to its short half-life. The discussion also covers the role of direct oral anticoagulants such as apixaban and rivaroxaban, noting their advantages and limitations, including the absence of pediatric-specific reversal agents. The speaker also addresses thrombolysis, particularly for life or organ-threatening thrombosis, and underscores that treatment decisions should involve multidisciplinary collaboration. The presentation concludes by introducing Pulmonary Embolism Response Teams (PERTs) to improve care decisions and outcomes in pediatric cases.
Asset Caption
One-Hour Concurrent Session | Pediatric Venous Thromboembolism: An Update on Predictive Risk Factors, Prevention, and Treatment
Meta Tag
Content Type
Presentation
Membership Level
Professional
Membership Level
Select
Year
2024
Keywords
pediatric venous thromboembolism
anticoagulants
direct oral anticoagulants
thrombolysis
Pulmonary Embolism Response Teams
×
Please select your language
1
English